{
  "docId": "019de076-08a6-76d8-a7d9-b68643d71f6f",
  "docSlug": "3a0354fd1e64f16191ffa0e33db132fd",
  "documentTitle": "MaxCyte | Investor Presentation Deck | 19 slides",
  "authorId": "maxcyte",
  "authorName": "MaxCyte",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 11,
  "pageCount": 19,
  "prevPage": 10,
  "nextPage": 12,
  "slideType": "business_model",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "Uses the 'Razor/Razor Blade' business model framework.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-08a6-76d8-a7d9-b68643d71f6f/11",
  "deckHref": "/decks/019de076-08a6-76d8-a7d9-b68643d71f6f",
  "deckJsonHref": "/decks/019de076-08a6-76d8-a7d9-b68643d71f6f.json",
  "deckAnchorHref": "/decks/019de076-08a6-76d8-a7d9-b68643d71f6f#slide-11",
  "components": [
    {
      "bbox": {
        "h": 0.25,
        "w": 0.92,
        "x": 0.045,
        "y": 0.35
      },
      "kind": "framework",
      "text": "Preclinical and Academic Revenue Model: Instrument Sale (ATx/GTx) + Single-use Disposables = Razor/Razor Blade Economics",
      "attrs": null,
      "subkind": "instance",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "394657ef-bf0e-4207-8ebf-0cecef3a5394",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.92,
        "x": 0.045,
        "y": 0.65
      },
      "kind": "framework",
      "text": "SPL Partnership Model: Annual Instrument License Fee (GTx) + Single-use Disposables + Strategic Partnership Terms = Razor/Razor Blade Economics and Share of Therapeutic Economics",
      "attrs": null,
      "subkind": "instance",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "baa604cf-c8de-4bce-9199-02125024ff9e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.3,
        "x": 0.22,
        "y": 0.42
      },
      "kind": "image",
      "text": "Product images of ATx and GTx instruments",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0972150b-4e5a-49d3-8f68-e8431efa6bfa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.11,
        "w": 0.58,
        "x": 0.045,
        "y": 0.17
      },
      "kind": "paragraph",
      "text": "CELL THERAPY – Cell itself is the Drug\nKey Applications: Ex-Vivo Engineered Cell Therapies\nCustomer Base: Leading global cell therapy developers and academic translational centers",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5a90fa49-ae1f-418e-b753-3a2365fd1596",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.59,
        "x": 0.045,
        "y": 0.07
      },
      "kind": "title",
      "text": "MaxCyte Business Model – Cell Therapy Market",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "37bd929b-3045-44b5-984f-2d67bb22ae29",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "razor-blade-model",
      "slug": null,
      "matchId": "73a0c7f9-60ae-428d-9400-24a4ef15afee",
      "evidence": "Explicit mention of 'Razor/Razor Blade Economics' and structure of recurring revenue from disposables.",
      "confidence": 1
    }
  ],
  "arcBeats": [
    {
      "to": 11,
      "from": 10,
      "beatId": "976459c1-7ff0-4493-b615-fc2c763afd88",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Business Model",
      "beatSlug": "sequoia-pitch-business-model",
      "evidence": "Slides 10-11 present MaxCyte's business model.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}